Clearstead Advisors, LLC Pfizer Inc Transaction History

Clearstead Advisors, LLC

$6.31 Billion
Q3 2024

A detailed history of Clearstead Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 222,909 shares of PFE stock, worth $5.89 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

222,909

Previous 218,897 1.83%

Holding current value

$5.89 Million

Previous $6.12 Million 5.32%

% of portfolio

0.1%

Previous 0.11%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$27.7 - $31.39 $111,132 - $125,936	4,012 Added 1.83%	222,909 $6.45 Million
Q2 2024 Aug 09, 2024	BUY	$25.26 - $29.6 $2.58 Million - $3.03 Million	102,263 Added 87.68%	218,897 $6.12 Million
Q1 2024 May 14, 2024	SELL	$25.89 - $29.73 $602,408 - $691,757	-23,268 Reduced 16.63%	116,634 $3.24 Million
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $391,819 - $508,930	-14,995 Reduced 9.68%	139,902 $4.03 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $726,036 - $848,663	-22,625 Reduced 12.74%	154,897 $5.14 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $514,627 - $601,547	16,037 Added 9.93%	177,522 $5.89 Million
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $994,889 - $1.15 Million	27,544 Added 20.56%	161,485 $5.92 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $68,932 - $89,740	1,750 Added 1.32%	133,941 $5.46 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $118,403 - $154,562	2,836 Added 2.19%	132,191 $6.78 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $851,132 - $1.04 Million	-19,450 Reduced 13.07%	129,355 $5.66 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $196,077 - $232,486	4,214 Added 2.91%	148,805 $7.8 Million
Q1 2022 May 04, 2022	BUY	$45.75 - $56.69 $186,339 - $230,898	4,073 Added 2.9%	144,591 $7.49 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $392,002 - $581,078	9,487 Added 7.24%	140,518 $8.3 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $188,243 - $241,814	-4,796 Reduced 3.53%	131,031 $5.64 Million
Q2 2021 Aug 12, 2021	BUY	$35.91 - $40.68 $361,972 - $410,054	10,080 Added 8.02%	135,827 $5.32 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $5,726 - $6,458	171 Added 0.14%	125,747 $4.56 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $345,276 - $439,048	10,316 Added 8.95%	125,576 $4.62 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $136,048 - $159,616	4,285 Added 3.86%	115,260 $4.23 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $70,812 - $85,905	2,351 Added 2.16%	110,975 $3.63 Million
Q1 2020 May 14, 2020	SELL	$27.03 - $38.62 $215,861 - $308,419	-7,986 Reduced 6.85%	108,624 $3.55 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $33,644 - $38,181	1,022 Added 0.88%	116,610 $4.57 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $26,186 - $33,956	-806 Reduced 0.69%	115,588 $4.15 Million
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $48,813 - $54,806	1,320 Added 1.15%	116,394 $5.04 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $139,575 - $153,346	3,722 Added 3.34%	115,074 $4.89 Million
Q4 2018 Feb 11, 2019	BUY	$38.47 - $43.86 $185,002 - $210,922	4,809 Added 4.51%	111,352 $4.86 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $150,323 - $182,333	-4,361 Reduced 3.93%	106,543 $4.7 Million
Q2 2018 Aug 07, 2018	BUY	$32.98 - $35.16 $172,089 - $183,464	5,218 Added 4.94%	110,904 $4.02 Million
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $188,237 - $218,380	-5,899 Reduced 5.29%	105,686 $3.75 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $567,748 - $602,400	-17,070 Reduced 13.27%	111,585 $4.04 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $3.99 Million - $4.39 Million	128,655	128,655 $4.59 Million

Others Institutions Holding PFE

# of Institutions

3,261

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearstead Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearstead Advisors, LLC with notifications on news.

Account

Clearstead Advisors, LLC Pfizer Inc Transaction History